Back to Authors

Graff-Radford, Jonathan

Mayo Clinic

Mayo Clinic

Citations 22

Objective assessment of patients with idiopathic normal pressure hydrocephalus following ventriculoperitoneal shunt placement using activity-monitoring data: pilot study
Jusué-Torres, Ignacio , Pennington, Zach , Ali, Farwa, Graff‐Radford, Neill R. , Cutsforth‐Gregory, Jeremy K. , Graff-Radford, Jonathan, Elder, Benjamin D. , Pennington, Zach , Jusue-Torres, Ignacio , Brown, Desmond , Cogswell, Petrice M. , Ali, Farwa , Jones, David , Graff‐Radford, Jonathan , Kaufman, Kenton R.

Neurosurgical Focus | April 1, 2023 | Volume: 54 | Issue: 4 | Pages: E6

10.3171/2023.1.focus22640 Get It

OBJECTIVE Idiopathic normal pressure hydrocephalus (iNPH) results in significant morbidity in the elderly with symptoms of dementia, gait instability, and urinary incontinence. In well-selected patients, ventriculoperitoneal shunt (VPS) placement often results in clinical improvement. Most postshunt assessments of patients rely on subjective scales. The goal of this study was to assess the utility of remote activity monitoring to provide objective evidence of gait improvement following VPS placement for iNPH. METHODS Patients with iNPH were prospectively enrolled and fitted with 5 activity monitors (on the hip and bilateral thighs and ankles) that they wore for 4 days preoperatively within 30 days of surgery and for 4 days within 30 days postoperatively. Monitors collected continuous data for number of steps, cadence, body position (upright, prone, supine, and lateral decubitus), gait entropy, and the proportion of each day spent active or static. Data were retrieved from the devices and a comparison of pre- and postoperative movement assessment was performed. The gait data were also correlated with formal clinical gait assessments before and after lumbar puncture and with motion analysis laboratory testing at baseline and 1 month and 1 year after VPS placement. RESULTS Twenty patients fulfilled the inclusion and exclusion criteria (median age 76 years). The baseline median number of daily steps was 1929, the median percentage of the day spent inactive was 70%, the median percentage of the day with a static posture was 95%, the median gait velocity was 0.49 m/sec, and the median number of steps required to turn was 8. There was objective improvement in median entropy from pre- to postoperatively, increasing from 0.6 to 0.8 (p = 0.002). There were no statistically significant differences for any of the remaining variables measured by the activity monitors when comparing the preoperative to the 1-month postoperative time point. All variables from motion analysis testing showed statistically significant differences or a trend toward significance at 1 year after VPS placement. Among the significantly correlated variables at baseline, cadence was inversely correlated with percentage of gait cycle spent in the support phase (contact with ground vs swing phase). CONCLUSIONS This pilot study suggests that activity monitoring provides an early objective measure of improvement in gait entropy after VPS placement among patients with iNPH, although a more significant improvement was noted on the detailed clinical gait assessments. Further long-term studies are needed to determine the utility of remote monitoring for assessing gait improvement following VPS placement.
Cognitive Impairment and Dementia After Stroke: Design and Rationale for the DISCOVERY Study
Rost, Natalia S. , Meschia, James F. , Wruck, Lisa , Helmer, Karl G. , Greenberg, Steven M. , Investigators*, on behalf of the DISCOVERY, Barrett, Kevin M. , Biffi, Alessandro , Fornage, Myriam , Etherton, Mark R. , Golland, Polina , Graff-Radford, Jonathan, Jack, Cliff R, Kalpathy–Cramer, Jayashree , Kittner, Steven J. , Lowe, Val J. , Petersen, Ronald C. , Sherman, Alexander , Viswanathan, Anand , Meschia, James F , Wruck, Lisa M , Gottesman, Rebecca F. , Investigators*, on behalf of the DISCOVERY, Boden-Albala, Bernadette M , Graff‐Radford, Jonathan , Hinman, Jason D. , Knopman, David S. , Manly, Jennifer J. , Mosley, Thomas H. , Rissman, Robert A. , Schirmer, Markus D. , Schwab, Kristin , Seshadri, Sudha , Sherman, Alexander, Vemuri, Prashanthi

Stroke | May 27, 2021 | Volume: 52 | Issue: 8 | Pages: No page available

10.1161/strokeaha.120.031611 Get It

Stroke is a leading cause of the adult disability epidemic in the United States, with a major contribution from poststroke cognitive impairment and dementia (PSCID), the rates of which are disproportionally high among the health disparity populations. Despite the PSCID’s overwhelming impact on public health, a knowledge gap exists with regard to the complex interaction between the acute stroke event and highly prevalent preexisting brain pathology related to cerebrovascular and Alzheimer disease or related dementia. Understanding the factors that modulate PSCID risk in relation to index stroke event is critically important for developing personalized prognostication of PSCID, targeted interventions to prevent it, and for informing future clinical trial design. The DISCOVERY study (Determinants of Incident Stroke Cognitive Outcomes and Vascular Effects on Recovery), a collaborative network of thirty clinical performance clinical sites with access to acute stroke populations and the expertise and capacity for systematic assessment of PSCID will address this critical challenge. DISCOVERY is a prospective, multicenter, observational, nested-cohort study of 8000 nondemented ischemic and hemorrhagic stroke patients enrolled at the time of index stroke and followed for a minimum of 2 years, with serial cognitive evaluations and assessments of functional outcome, with subsets undergoing research magnetic resonance imaging and positron emission tomography and comprehensive genetic/genomic and fluid biomarker testing. The overall scientific objective of this study is to elucidate mechanisms of brain resilience and susceptibility to PSCID in diverse US populations based on complex interplay between life-course exposure to multiple vascular risk factors, preexisting burden of microvascular and neurodegenerative pathology, the effect of strategic acute stroke lesions, and the mediating effect of genomic and epigenomic variation.